Real-world Impact of Tezepelumab in Severe Asthma: insights from the ADVANCAT Study (Advancing Severe Asthma Care with Tezepelumab in Catalonia)
Por:
Arismendi, E, Basagaña, M, Crespo, A, Luengo, O, Martinez-Rivera, C, Muñoz-Esquerre, M, Paredes, M, Ojanguren, I and Munoz, X
Publicada:
1 sep 2025
Resumen:
Filiaciones:
Arismendi, E:
Univ Barcelona, Hosp Clin Barcelona, Pulmonol Dept, CIBERES, Barcelona, Spain
:
Hosp Germans Trias I Pujol, Allergol Dept, Barcelona, Spain
Crespo, A:
Hosp Santa Creu i St Pau, Pulmonol Dept, Barcelona, Spain
Luengo, O:
Hosp Valle De Hebron, Allergol Dept, Barcelona, Spain
:
Hosp Germans Trias i Pujol, Pulmonol Dept, Barcelona, Spain
Muñoz-Esquerre, M:
Hosp Univ Bellvitge, Pulmonol Dept, Barcelona, Spain
Paredes, M:
Hosp Clin Barcelona, Pulmonol Dept, Barcelona, Spain
Ojanguren, I:
Hosp Valle De Hebron, Pulmonol Dept, Barcelona, Spain
Munoz, X:
Hosp Valle De Hebron, Pulmonol Dept, Barcelona, Spain
|